Abstract：
PURPOSE:To present recommendations for the use of brachytherapy (BT) in patients with soft tissue sarcoma (STS). METHODS:A group of practitioners with expertise and experience in sarcoma BT formulated recommendations for BT in STS based on clinical experience and literature review. RESULTS:The indications for adjuvant BT are discussed. There is no consensus on the use of BT alone or in combination with external beam radiation therapy (EBRT), but factors that influence the selection of this modality include tumor grade and size, prior surgeries, and tumor recurrence. Low-dose-rate, high-dose-rate, and pulsed-dose-rate radiation are all acceptable BT modalities to use for STS. Recommendations are made for patient selection, techniques, dose rates, and dosages. Outcome data and toxicity data are reviewed. CONCLUSIONS:BT is a useful component of the treatment of STS. The advantages of BT are the targeted dose distribution, low integral dose, and short treatment times. Ultimately the clinician should select the modality or combination of modalities that are most familiar to the treatment team and suitable to the patient.
journal_name
Brachytherapyjournal_title
Brachytherapyauthors
Holloway CL,Delaney TF,Alektiar KM,Devlin PM,O'Farrell DA,Demanes DJdoi
10.1016/j.brachy.2012.12.002subject
Has Abstractpub_date
2013-05-01 00:00:00pages
179-90issue
3eissn
1538-4721issn
1873-1449pii
S1538-4721(13)00198-0journal_volume
12pub_type
杂志文章,评审相关文献
Brachytherapy文献大全abstract：PURPOSE:Low-dose-rate brachytherapy using iodine-125 seeds is a highly efficacious treatment for low-risk prostate cancer. We propose a bioeffect model may be used to target an ablative dose to the tumor with a lower, therapeutic dose to low-risk regions to maintain high rates of tumor control with reduced toxicity. We...
journal_title：Brachytherapy
pub_type： 杂志文章,多中心研究
doi：10.1016/j.brachy.2013.04.008
更新日期：2013-11-01 00:00:00
abstract：PURPOSE:GammaTile cesium-131 (131Cs) permanent brain implant has received Food and Drug Administration (FDA) clearance as a promising treatment for certain brain tumors. Our center was the first institution in the United States after FDA clearance to offer the clinical use of GammaTile brachytherapy outside of a clinic...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2020.12.005
更新日期：2021-01-21 00:00:00
abstract：PURPOSE:To evaluate the preliminary results of vaginal-cuff relapses (VCR) and complications of a short brachytherapy (BT) schedule in postoperative endometrial carcinoma. METHODS AND MATERIALS:From September 2011 to December 2014, 102 patients were treated with postoperative BT for endometrial carcinoma. Seventy-four...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2016.10.001
更新日期：2017-01-01 00:00:00
abstract：PURPOSE:To choose the optimal brachytherapeutic modality for uterine cervical cancer, we performed simulation analysis. METHODS AND MATERIALS:For each high-risk clinical target volume (HR CTV), we compared four modalities [classical conventional intracavitary brachytherapy (ConvICBT), Image-guided ICBT (IGICBT), intra...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2015.10.002
更新日期：2016-01-01 00:00:00
abstract：PURPOSE:To compare a standard radio-oncological and a surgical biochemical failure definition after combined-modality radiation therapy (CRT) in men with intermediate- and high-risk prostate cancer. METHODS:425 men were treated with external beam radiotherapy (59.4 Gy, 33 fractions) and 125J seed-brachytherapy (S-BT, ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.09.001
更新日期：2020-01-01 00:00:00
abstract：PURPOSE:To analyze the effect of tungsten shields present in a Fletcher-Suit-Delclos ovoid by comparing the dose distribution computed by a treatment planning system (TPS) to the delivered dose distribution measured by radiochromic film dosimetry. METHODS AND MATERIALS:Gafchromic/EBT films were carefully wrapped aroun...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2010.08.008
更新日期：2011-05-01 00:00:00
abstract：PURPOSE:Treatment of locally advanced cervical cancer in patients with a renal graft requires precautions. The graft is usually in a pelvic position, close to the clinical target volume (CTV). Preserving the graft while ensuring local control is a challenge we have faced in two occasions. We report our experience. MET...
journal_title：Brachytherapy
pub_type： 社论
doi：10.1016/j.brachy.2013.11.003
更新日期：2014-01-01 00:00:00
abstract：:While brachytherapy applications are not widely used for cancer diagnoses in the upper GI tract (including the esophagus, liver, stomach, and pancreas), they have a clear role in palliation and symptom management and occasionally definitive locoregional treatment. With the increasing use of image-guided techniques, th...
journal_title：Brachytherapy
pub_type： 杂志文章,评审
doi：10.1016/j.brachy.2020.11.010
更新日期：2020-12-22 00:00:00
abstract：PURPOSE:Certain subsets of patients have an increased risk of all-cause mortality when androgen deprivation therapy (ADT) is used with definitive radiotherapy. We evaluated the relationship between pretreatment serum testosterone, age, and comorbidities on survival after prostate brachytherapy in men treated with and w...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2009.06.008
更新日期：2010-01-01 00:00:00
abstract：PURPOSE:In 2012, our institution transitioned from low-dose-rate (LDR) brachytherapy to high dose-rate (HDR) brachytherapy. We report clinical outcomes after brachytherapy for cervical cancer at our institution over a continuous 10-year period. METHODS AND MATERIALS:From 2004 to 2014, 258 women (184 LDR and 74 HDR) we...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2016.12.005
更新日期：2017-01-01 00:00:00
abstract：PURPOSE:Although current Delphi Consensus guidelines do not recommend a specific definition of biochemical recurrence after partial gland therapy, these guidelines acknowledge that serial prostate-specific antigen (PSA) tests remain the best marker for monitoring disease after treatment. The purpose of this study was t...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2018.12.001
更新日期：2019-01-01 00:00:00
abstract：PURPOSE:To evaluate outcomes after exclusive salvage high-dose-rate (HDR) intraluminal esophageal brachytherapy given to previously irradiated patients with recurrent esophageal cancer. METHODS AND MATERIALS:We reviewed medical records of 30 patients who were treated by salvage HDR brachytherapy for local esophageal c...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2015.02.392
更新日期：2015-07-01 00:00:00
abstract：PURPOSE:There is strong evidence relating postimplant dosimetry for low-dose-rate prostate seed brachytherapy to local control rates. The delineation of the prostate on CT images, however, represents a challenge due to the lack of soft-tissue contrast to identify the prostate borders. This study aims at quantifying the...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2016.08.013
更新日期：2016-01-01 00:00:00
abstract：PURPOSE:To validate the 2019 NCCN subgroups of favorable- and unfavorable-intermediate risk (IR) prostate cancer among patients treated with brachytherapy, who are underrepresented in the studies used to develop the 2019 NCCN classification. METHODS:We included all 2,705 men treated with I-125 LDR brachytherapy monoth...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.10.005
更新日期：2020-01-01 00:00:00
abstract：PURPOSE:The use of brachytherapy continues to be a vital application of radiation oncology for various cancers. Despite this, there has been a decrease in the utilization of brachytherapy in many cancers. Social media in medicine facilitates engagement and advocacy. We launched a social media campaign to bring awarenes...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2020.07.003
更新日期：2021-01-01 00:00:00
abstract：PURPOSE:This is a retrospective review of our experience using high-dose-rate (HDR) brachytherapy boost for prostate cancer. METHODS AND MATERIALS:During the study period, we recommended external beam radiotherapy (45 Gy) and HDR boost (18 Gy in three fractions) combined with hormonal therapy (HT) for 2 months before ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2005.03.005
更新日期：2005-01-01 00:00:00
abstract：PURPOSE:To report prostate-specific antigen (PSA) relapse-free survival and treatment-related toxicity outcomes after combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) for patients with clinically localized prostate cancer. METHODS AND MATERIALS:Between 1998 and 2009, 229 patients wer...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2012.05.003
更新日期：2013-01-01 00:00:00
abstract：PURPOSE:To evaluate lumpectomy followed by interstitial brachytherapy as an acceptable salvage therapy for women who have developed localized recurrence of breast cancer after conservation surgery and postoperative external radiotherapy. METHODS AND MATERIALS:Between 1/1998 and 10/2006, 21 patients with T0 or T1 in-br...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2007.12.001
更新日期：2008-01-01 00:00:00
abstract：PURPOSE:The aim of this study was to retrospectively observe and analyze the long-term treatment outcomes for a total of 952 esophageal cancer patients who were treated with (252)Cf neutron brachytherapy (NBT) in combination with external beam radiotherapy (EBRT). METHODS AND MATERIALS:From November 2001 to March 2012...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2014.03.004
更新日期：2014-09-01 00:00:00
abstract：PURPOSE:With accumulating evidence supporting partial-breast irradiation, we conducted a Phase I/II study to evaluate the role of a second conservative surgery and brachytherapy for patients presenting with a local recurrence/new primary in a breast who has previously undergone a lumpectomy and external radiation thera...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2007.10.006
更新日期：2008-01-01 00:00:00
abstract：PURPOSE:To analyze the dosimetric impact and periprocedural outcomes with a bioabsorbable hydrogel rectal spacer injected during low-dose-rate (LDR) prostate brachytherapy implants. METHODS AND MATERIALS:A consecutive series of 80 patients implanted with stranded I-125 LDR brachytherapy seeds were evaluated, of which ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.11.002
更新日期：2020-01-01 00:00:00
abstract：BACKGROUND:This study was undertaken to determine the feasibility of perioperative high-dose-rate brachytherapy (PHDRB) as an adjunct to salvage surgery in primary advanced or recurrent gynecologic cancer. METHODS:Twenty-five patients with either locally advanced (n = 4) or recurrent (n = 21) gynecologic cancer suitab...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2006.07.001
更新日期：2006-10-01 00:00:00
abstract：PURPOSE:To provide longitudinal follow-up and assess the intermediate outcomes in breast cancer patients treated with the MammoSite radiation therapy system. METHODS AND MATERIAL:Ninety-two patients with histologically proven stage 0-II breast cancer were treated with MammoSite accelerated partial breast irradiation a...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2008.07.005
更新日期：2009-01-01 00:00:00
abstract：PURPOSE:High-dose-rate (HDR) brachytherapy is a convenient treatment option for selected patients with T1-T2 penile squamous cell carcinoma (SCC), providing high rates of penile preservation and tumor control. We present the results of penile SCC treated with HDR brachytherapy either interstitially or via a surface mol...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.12.003
更新日期：2020-01-01 00:00:00
abstract：PURPOSE:To describe the use of dual source strength implants for focal low-dose-rate brachytherapy. METHODS AND MATERIALS:An interneedle dual source strength planning strategy is described for focal low-dose-rate brachytherapy of the prostate. The implanted treatment plans were designed using peripheral (except near t...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2016.04.388
更新日期：2016-09-01 00:00:00
abstract：PURPOSE:Accelerated partial breast irradiation (APBI) continues to increase in popularity. Up to 14% of patients treated with the MammoSite (MS) report some degree of chronic pain, which may be related to chest wall toxicity. Reports from several institutions using the multicatheter (MC) technique have not shown associ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2008.11.007
更新日期：2009-04-01 00:00:00
abstract：OBJECTIVE:To determine the usefulness of prostate-specific antigen (PSA) percentage (vs. pretreatment value assumed as 100%) in prediction of biochemical relapse, after iodine-125 ((125)I) permanent brachytherapy for prostate cancer, to employ a parameter independent by the initial PSA amount and by the individual pros...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2011.08.008
更新日期：2012-07-01 00:00:00
abstract：PURPOSE:While the noninvasive breast brachytherapy (NIBB) treatment procedure, known as AccuBoost, for breast cancer patients is well established, the treatment quality can be improved by the efficiency of the workflow delivery. A formalized approach evaluated the current workflow through failure modes and effects anal...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2020.01.007
更新日期：2020-01-01 00:00:00
abstract：UNLABELLED:PURPOSE/INTRODUCTION: To safely irradiate retroperitoneal targets as paraaortic lymph node by separating abdominal at-risk organs from the target during irradiation, we created a percutaneous paravertebral approach of high-dose-rate brachytherapy with hyaluronate gel injection (HGI). We report a case treated...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2011.12.004
更新日期：2013-01-01 00:00:00
abstract：PURPOSE:The aim of this work was to analyze the results of palliative HDR brachytherapy in patients with advanced esophageal cancer. METHODS AND MATERIALS:Ninety-one patients with unresectable, advanced esophageal cancer were treated palliatively by HDR brachytherapy. All patients received a total dose of 22.5 Gy in t...
journal_title：Brachytherapy
pub_type： 临床试验,杂志文章
doi：10.1016/j.brachy.2004.05.003
更新日期：2004-01-01 00:00:00
